Active12518247Private limited companyHenley-On-Thames

BEAUMONT PHARMA LTD

Significant control: Jane Anne Sharples (25–50%), Shafiq Mohammed Choudhary (significant control)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Beaumont Pharma Ltd sell?

Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

BEAUMONT PHARMA LTD is an active private limited company (company number 12518247) incorporated on 16 March 2020, registered in Henley-On-Thames. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 31 March 2025, showing net assets of £468k and cash of £310k, with 2 employees on average. Net assets rose 33% on the prior period (£352k).

Peer position · net assets

By net assets it sits in the top quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).

02

Ownership and control

2 active · 2 other
  • Dr Jane Anne Sharples
    Individual · since 16 March 2020
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mr Shafiq Mohammed Choudhary
    Individual · since 3 July 2026
    • has significant influence or control
  • Mrs Mineza Maher
    Individual · since 16 March 2020 · ceased 12 May 2023
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mrs Robina Shafiq
    Individual · since 12 May 2023 · ceased 3 July 2026
    • owns 25–50% of shares

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
16 March 20206 yrs ago
Next accounts due
31 December 2026in 69 days
Confirmation statement due
30 March 2027in 158 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 46460
Wholesale of pharmaceutical goods
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 March 2025
Net assets
£468k
+33%vs Mar 2024
Cash at bank
£310k
+22%vs Mar 2024
Turnover
Not reported
Employees
2
No changevs Mar 2024
Net assets
£468k
Cash at bank
£310k
Average employees
2
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 March 2025£468k£310k£624k£1.42m——2
31 March 2024£352k£255k£460k£1.31m——2
Current ratio1.33Current assets ÷ creditors within one year
Cash per employee£155kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £467,822 at 31 March 2025
  • Net assets up 10% or more on the prior period+33.0% vs prior period
  • Cash at bank of £50,000 or moreCash £309,660
  • Incorporated five or more years agoIncorporated 16 March 2020

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 158 days
  2. Next accounts duein 69 days
  3. Accounts period endNet assets £468k · small accounts
  4. Accounts period endNet assets £352k · small accounts
  5. Incorporated
08

Similar companies in Reading

Same activity (wholesale of pharmaceutical goods), closest in incorporation date
09

Reminders for BEAUMONT PHARMA LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.